JP2010503409A - クプレドキシンによって癌を予防する組成物および方法 - Google Patents

クプレドキシンによって癌を予防する組成物および方法 Download PDF

Info

Publication number
JP2010503409A
JP2010503409A JP2009528468A JP2009528468A JP2010503409A JP 2010503409 A JP2010503409 A JP 2010503409A JP 2009528468 A JP2009528468 A JP 2009528468A JP 2009528468 A JP2009528468 A JP 2009528468A JP 2010503409 A JP2010503409 A JP 2010503409A
Authority
JP
Japan
Prior art keywords
cancer
cupredoxin
azurin
peptide
residues
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2009528468A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010503409A5 (enExample
Inventor
ダス・グプタ、タパス
チャクラバーティ、アナンダ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Illinois System
Original Assignee
University of Illinois System
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Illinois System filed Critical University of Illinois System
Publication of JP2010503409A publication Critical patent/JP2010503409A/ja
Publication of JP2010503409A5 publication Critical patent/JP2010503409A5/ja
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/21—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/104—Pseudomonadales, e.g. Pseudomonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2009528468A 2006-09-14 2007-09-13 クプレドキシンによって癌を予防する組成物および方法 Withdrawn JP2010503409A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84435806P 2006-09-14 2006-09-14
PCT/US2007/078371 WO2008033987A2 (en) 2006-09-14 2007-09-13 Compositions and methods to prevent cancer with cupredoxins

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013209725A Division JP2014050390A (ja) 2006-09-14 2013-10-04 クプレドキシンによって癌を予防する組成物および方法

Publications (2)

Publication Number Publication Date
JP2010503409A true JP2010503409A (ja) 2010-02-04
JP2010503409A5 JP2010503409A5 (enExample) 2010-11-04

Family

ID=39184582

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2009528468A Withdrawn JP2010503409A (ja) 2006-09-14 2007-09-13 クプレドキシンによって癌を予防する組成物および方法
JP2013209725A Pending JP2014050390A (ja) 2006-09-14 2013-10-04 クプレドキシンによって癌を予防する組成物および方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2013209725A Pending JP2014050390A (ja) 2006-09-14 2013-10-04 クプレドキシンによって癌を予防する組成物および方法

Country Status (13)

Country Link
EP (1) EP2061498A4 (enExample)
JP (2) JP2010503409A (enExample)
KR (1) KR20090059152A (enExample)
CN (1) CN101595124A (enExample)
AU (1) AU2007296429A1 (enExample)
BR (1) BRPI0714987A2 (enExample)
CA (1) CA2663498A1 (enExample)
IL (1) IL197602A0 (enExample)
MX (1) MX2009002787A (enExample)
NO (1) NO20091267L (enExample)
RU (1) RU2009113812A (enExample)
SG (1) SG174784A1 (enExample)
WO (1) WO2008033987A2 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7556810B2 (en) 2005-07-19 2009-07-07 The Board Of Trustees Of The University Of Ilinois Compositions and methods to control angiogenesis with cupredoxins
US9096663B2 (en) 2001-02-15 2015-08-04 The Board Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins and mutants thereof
US7381701B2 (en) 2001-02-15 2008-06-03 The Borad Of Trustees Of The University Of Illinois Compositions and methods for treating conditions related to ephrin signaling with cupredoxins
US9598470B2 (en) * 2004-10-07 2017-03-21 Craig W. Beattie Compositions and methods to prevent cancer by stabilizing P53 through non MDM2-mediated pathways
US10675326B2 (en) 2004-10-07 2020-06-09 The Board Of Trustees Of The University Of Illinois Compositions comprising cupredoxins for treating cancer
US9434770B2 (en) 2004-10-07 2016-09-06 Tapas K Das Gupta Modified cupredoxin derived peptides
CN101437842A (zh) 2004-10-07 2009-05-20 阿南达·查克拉博蒂 铜氧还蛋白衍生的转运制剂及其应用方法
US9968685B2 (en) 2004-10-07 2018-05-15 Brad N. Taylor Methods to treat cancer with cupredoxins
CA2615617A1 (en) 2005-07-19 2007-01-25 The Board Of Trustees Of The University Of Illinois Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof
CA2671492A1 (en) * 2006-12-04 2008-06-12 The Board Of Trustees Of The University Of Illinois Compositions and methods to treat cancer with cupredoxins and cpg rich dna
EP2114429A4 (en) * 2007-02-08 2010-05-19 Univ Illinois COMPOSITIONS AND METHOD FOR CANCER PREPARATION WITH CUPREDOXINES
CA3075836A1 (en) * 2017-09-29 2019-04-04 Oncgnostics Gmbh Risk determination for neoplasia and cancer

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
US20060149037A1 (en) * 2004-10-07 2006-07-06 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1506375A (zh) * 2002-12-12 2004-06-23 浙江养生堂天然药物研究所有限公司 具有广谱抗肿瘤作用的细菌蛋白天青蛋白及其用途和含有其的药物组合物
JP2008539795A (ja) * 2005-05-20 2008-11-20 ザ・ボード・オブ・トラスティーズ・オブ・ザ・ユニバーシティ・オブ・イリノイ キュプレドキシンを用いたエフリン信号伝達に関する症状を治療するための組成物および方法
EP1904081A4 (en) * 2005-07-19 2008-12-03 Univ Illinois COMPOSITIONS AND METHODS FOR CONTROLLING AN ANGIOGENESIS WITH CUPREDOXINES

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018662A1 (en) * 2003-08-15 2005-03-03 Board Of Trustees Of The University Of Illinois Use of polypeptides of the cupredoxin family in cancer therapy
US20060149037A1 (en) * 2004-10-07 2006-07-06 Ananda Chakrabarty Cupredoxin derived transport agents and methods of use thereof

Also Published As

Publication number Publication date
EP2061498A4 (en) 2009-11-04
RU2009113812A (ru) 2010-10-20
WO2008033987A3 (en) 2009-04-30
SG174784A1 (en) 2011-10-28
JP2014050390A (ja) 2014-03-20
WO2008033987A2 (en) 2008-03-20
CA2663498A1 (en) 2008-03-20
EP2061498A2 (en) 2009-05-27
MX2009002787A (es) 2009-08-27
AU2007296429A1 (en) 2008-03-20
KR20090059152A (ko) 2009-06-10
NO20091267L (no) 2009-06-04
IL197602A0 (en) 2011-08-01
CN101595124A (zh) 2009-12-02
BRPI0714987A2 (pt) 2013-07-30

Similar Documents

Publication Publication Date Title
JP2014050390A (ja) クプレドキシンによって癌を予防する組成物および方法
US10117905B2 (en) Compositions and methods to prevent cancer with cupredoxins
US10086037B2 (en) Compositions and methods to prevent cancer with cupredoxins
US10351605B2 (en) Compositions and methods to prevent cancer by stabilizing p53 through non MDM2-mediated pathways
CN101600447A (zh) 铜氧还蛋白衍生肽类的修饰物及其使用方法
US8158574B2 (en) Compositions and methods to prevent cancer with cupredoxins
JP2012512892A (ja) クプレドキシンを用いて癌を防止する組成物及び方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100913

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20100913

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20121113

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130213

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130220

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20130311

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20130318

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20130604

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20131004

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20131009